Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01537978 · ClinicalTrials.gov registry record · Phase 1
Use of Interactive Gaming for Enhanced Function After Spinal Cord Injury
A Phase 1 study, sponsored by VA Palo Alto Health Care System.
- Completed
- Registry status
- Phase 1
- Development phase
- 21
- Enrollment target
NCT01537978: Completed Phase 1 study, sponsored by VA Palo Alto Health Care System.
NCT01537978 is a Phase 1 study that has completed, run by VA Palo Alto Health Care System. The registered enrollment target is 21 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (65% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01537978, a Phase 1 study, has completed, sponsored by VA Palo Alto Health Care System.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 21 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate whether there are functional improvements in arm muscles and movments for spinal cord injured indviduals after performing video gaming.
Primary Outcome
EMG will be measured at baseline testing for video game play and post testing after the videogaming is completed.
Interventions
- OTHER Video gaming for enhanced function after spinal cord injury.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2012-02 |
| Est. Completion | 2012-10 |
| Phase | Phase 1 |
What the finished NCT01537978 record still lists
NCT01537978 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (65% lower).
The record links to 0 conditions, and to 1 intervention - of which Video gaming for enhanced function after spinal cord injury. is the first listed.
NCT01537978 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01537978 about?
NCT01537978 is a clinical study titled "Use of Interactive Gaming for Enhanced Function After Spinal Cord Injury". The purpose of this study is to evaluate whether there are functional improvements in arm muscles and movments for spinal cord injured indviduals after performing video gaming.
What is the current status of trial NCT01537978?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 21 participants. The study started on 2012-02. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01537978?
The interventions under investigation include: Video gaming for enhanced function after spinal cord injury. (OTHER).
Who is sponsoring clinical trial NCT01537978?
This trial is sponsored by VA Palo Alto Health Care System, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01537978's enrollment target sits among peer trials
21 1615th of 2000 higher than 372 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia